Lubiński Wojciech, Gronkowska-Serafin Jolanta, Podboraczyńska-Jodko Karolina, Karczewicz Danuta
Clinic of Ophthalmology, Pomeranian Medical University, Szczecin, Poland.
Klin Oczna. 2009;111(10-12):327-31.
To evaluate the visual outcome, spectacles independence, contrast sensitivity (CS), subjective symptoms, patient satisfaction and complications three and 12 months after cataract surgery with bilateral ReZoom multifocal refractive intraocular lens (IOL) implantation.
This study comprised 40 eyes of selected 20 patients who had uneventful cataract surgery with bilateral implantation of ReZoom (AMO) multifocal IOL. Three and 12 months after bilateral surgery binocular uncorrected, the best corrected distance, near and uncorrected intermediate visual acuities (VA), spectacle independence, the best corrected binocular distance (with and without glare), near photopic CS, subjective symptoms, patient satisfaction and complications were evaluated.
Three and 12 months after surgery all patients had binocular uncorrected distance visual acuity (VA) of 0.5 or better; the best corrected distance VA was 1.0 in all cases. Three months after surgery, the mean binocular uncorrected intermediate VA was J4.10. The mean binocular uncorrected and the best corrected near VA were J3.10 and J1.70 respectively. Total spectacle independence and independence for distance, intermediate and near vision were achieved in 65%, 100%, 95% and 70% of patients respectively. The best corrected binocular distance and near CS were within normal limits. The most frequent subjective symptoms were mild glare and halo (65%--13/20 of patients).Total vision satisfaction was very high (9.6/ 10). There were no postoperative complications. One year after surgery, statistically significant improvement occurred in the best distance corrected near VA (p < 0.04), photopic distance best corrected CS without glare for 12 cycl/deg (p < 0.03) and in the level perception of glare/halo (p < 0.02) in comparison to the results from 3 months follow-up. The rest of analyzed parameters was unchanged. No complications were noticed except posterior capsule opacification in four patients one year after surgery who needed YAG laser treatment.
Bilateral ReZoom multifocal IOL implantation was effective in selected cataract patients, providing very good uncorrected distance, intermediate, and near visual acuities as well as very high level of patient satisfaction. Longer than three months of the neuroadaptation time after bilateral surgery is necessary to obtain significantly better visual function results.
评估双侧植入ReZoom多焦点屈光性人工晶状体(IOL)的白内障手术后3个月和12个月时的视力结果、眼镜独立性、对比敏感度(CS)、主观症状、患者满意度及并发症情况。
本研究纳入20例患者的40只眼,这些患者均顺利接受了双侧ReZoom(AMO)多焦点IOL植入的白内障手术。在双侧手术后3个月和12个月时,评估双眼未矫正、最佳矫正远视力、近视力及未矫正中视力(VA)、眼镜独立性、最佳矫正双眼远视力(有眩光和无眩光情况下)、明视近CS、主观症状、患者满意度及并发症情况。
术后3个月和12个月时,所有患者双眼未矫正远视力(VA)均为0.5或更好;所有病例最佳矫正远视力均为1.0。术后3个月,双眼未矫正中视力平均为J4.10。双眼未矫正和最佳矫正近视力平均分别为J3.10和J1.70。分别有65%、100%、95%和70%的患者实现了完全眼镜独立性以及远、中、近视力的独立性。最佳矫正双眼远视力和近CS均在正常范围内。最常见的主观症状是轻度眩光和光晕(65%——20例患者中的13例)。总体视觉满意度非常高(9. /10)。无术后并发症。与3个月随访结果相比,术后1年,最佳矫正近视力(p < 0.04)、无眩光情况下12周/度的明视远最佳矫正CS(p < 0.03)以及眩光/光晕的水平感知(p < 0.02)有统计学显著改善。其余分析参数未改变。术后1年,除4例患者出现后囊膜混浊并需要YAG激光治疗外,未发现其他并发症。
双侧植入ReZoom多焦点IOL对特定白内障患者有效,可提供非常好的未矫正远、中、近视力以及很高的患者满意度。双侧手术后需要超过3个月的神经适应时间才能获得明显更好的视觉功能结果。